BENITA QUALLS: Open Payments
NPI 1629245634 · LEBANON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,136 in 103 payments from 25 companies in 2025. Trend: 2023 $2,047 · 2024 $2,050 · 2025 $2,136
Food & beverage: $2,136
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $340 |
| AstraZeneca Pharmaceuticals LP | 10 | $272 |
| GlaxoSmithKline, LLC. | 14 | $242 |
| Amgen Inc. | 12 | $147 |
| PFIZER INC. | 8 | $144 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $128 |
| Vanda Pharmaceuticals Inc. | 2 | $122 |
| Corcept Therapeutics | 1 | $115 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $89 |
| Lilly USA, LLC | 4 | $76 |
Products named: TRELEGY ELLIPTA, Ozempic, AIRSUPRA, OTEZLA, Kerendia, Korlym, FANAPT, JARDIANCE.
Industry payments across TN — which companies pay providers there.
